TenNor Therapeutics (Suzhou) Limited (HKG:6872)
205.40
-0.40 (-0.19%)
Jul 10, 2026, 4:08 PM HKT
HKG:6872 Market Cap
HKG:6872 has a market cap or net worth of 10.63 billion as of July 10, 2026.
Market Cap
10.63B
Enterprise Value
10.46B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
205.40
Market Cap Chart
Since May 22, 2026, HKG:6872's market cap has decreased from 10.92B to 10.63B, a decrease of -2.65%. That is a compound annual growth rate of -18.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 10.63B | -0.19% |
| Jul 9, 2026 | 10.65B | 0.19% |
| Jul 8, 2026 | 10.63B | 4.53% |
| Jul 7, 2026 | 10.17B | -2.04% |
| Jul 6, 2026 | 10.38B | 0.10% |
| Jul 3, 2026 | 10.37B | 0.20% |
| Jul 2, 2026 | 10.35B | -8.51% |
| Jun 30, 2026 | 11.31B | -6.98% |
| Jun 29, 2026 | 12.16B | -3.05% |
| Jun 26, 2026 | 12.55B | -4.04% |
| Jun 25, 2026 | 13.07B | -4.17% |
| Jun 24, 2026 | 13.64B | -3.44% |
| Jun 23, 2026 | 14.13B | 1.11% |
| Jun 22, 2026 | 13.97B | 1.96% |
| Jun 18, 2026 | 13.70B | 3.04% |
| Jun 17, 2026 | 13.30B | 1.18% |
| Jun 16, 2026 | 13.15B | 2.42% |
| Jun 15, 2026 | 12.83B | -5.42% |
| Jun 12, 2026 | 13.57B | 8.53% |
| Jun 11, 2026 | 12.50B | 5.04% |
| Jun 10, 2026 | 11.90B | 9.21% |
| Jun 9, 2026 | 10.90B | -1.59% |
| Jun 8, 2026 | 11.08B | -0.65% |
| Jun 5, 2026 | 11.15B | 4.66% |
| Jun 4, 2026 | 10.65B | 0.68% |
| Jun 3, 2026 | 10.58B | 6.24% |
| Jun 2, 2026 | 9.96B | -4.75% |
| Jun 1, 2026 | 10.45B | -0.79% |
| May 29, 2026 | 10.54B | -3.05% |
| May 28, 2026 | 10.87B | -2.33% |
| May 27, 2026 | 11.13B | -8.74% |
| May 26, 2026 | 12.19B | 11.66% |
| May 22, 2026 | 10.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shaanxi Micot Pharmaceutical Technology | 14.29B |
| GenFleet Therapeutics (Shanghai) | 14.21B |
| Ascentage Pharma Group International | 13.38B |
| Ascletis Pharma | 11.86B |
| HBM Holdings | 10.11B |
| Nanjing Leads Biolabs | 9.93B |
| Everest Medicines | 9.67B |
| CARsgen Therapeutics Holdings | 9.21B |